FDA Drug recall D-103-2013
Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceutic…
- FDA Drug
- Class II
- terminated
- Published 2013-01-02
On 2013-01-02 the FDA classified a Class II recall of Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceutic… by Lloyd, citing subpotent; 9-month stability interval.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-103-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-07-25 |
| Published | 2013-01-02 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Lloyd |
| Distribution | US |
Product
Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
Reason
Subpotent; 9-month stability interval
Identifiers
| code_info | Lot 1094098, exp. date 9/2012 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-103-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.